958
K. Kokubo et al. / Tetrahedron Letters 51 (2010) 955–958
NO2
NO2
3%
δ
7.46
H
H
O
NOE 5%
NO2
O
H
O
BF3·Et2O
O
+
CHCl3, rt, 50 h
H
δ
7.15
OH
OH
O
1a
2c
3ac (51%)
4ac (11%)
Scheme 3. BF3-mediated cycloaddition of benzoquinone 1a with unsymmetrical oxirane 2c.
1998, 63, 1323; (f) Roshchin, A. I.; Kel0chevski, S. M.; Bumagin, N. A. J.
Organomet. Chem. 1998, 560, 163; (g) Chiba, K.; Fukuda, M.; Kim, S.; Kitano, Y.;
Tada, M. J. Org. Chem. 1999, 64, 7654; (h) Lattanzi, A.; Scettri, A. Synlett 2002,
942; (i) Konno, T.; Chae, J.; Ishihara, T.; Yamanaka, H. Tetrahedron 2004, 60,
11695; (j) Yoshida, M.; Morishita, Y.; Fujita, M.; Ihara, M. Tetrahedron Lett.
2004, 45, 1861; (k) Mattson, A. E.; Scheidt, K. A. J. Am. Chem. Soc. 2007, 129,
4508; (l) Bérard, D.; Racicot, L.; Sabot, C.; Canesi, S. Synlett 2008, 1076; (m)
Gabriele, B.; Mancuso, R.; Salerno, G. J. Org. Chem. 2008, 73, 7336; (n) Sakai, N.;
Uchida, N.; Konakahara, T. Tetrahedron Lett. 2008, 49, 3437.
limitations of the proposed reaction with a variety of substitu-
ents.
Acknowledgments
This work was partly supported by Grant-in-Aid for Scientific
Research from the Ministry of Education, Culture, Sports, Science,
and Technology, Japan. Authors thank Professor Long Y. Chiang
and Ms. Joshna Chittigori (UMass Lowell) for their helpful discus-
sion on the reaction mechanism.
6. (a) Dupont, R.; Cotelle, P. Tetrahedron 2001, 57, 5585; (b) Zhang, J.; Zhang, Y.;
Zhang, Y.; Herndon, W. Tetrahedron 2003, 59, 5609; (c) Zhang, H.; Ferreira, E.
M.; Stoltz, B. M. Angew. Chem., Int. Ed. 2004, 43, 6144; (d) Cruz, M. delC.;
Tamariz, J. Tetrahedron Lett. 2004, 45, 2377; (e) Xie, X.; Chen, B.; Lu, J.; Han, J.;
She, X.; Pan, X. Tetrahedron Lett. 2004, 45, 6235.
7. (a) Mukaiyama, T.; Sagawa, Y.; Kobayashi, S. Chem. Lett. 1987, 2169; (b) Engler,
T. A.; Draney, B. W.; Gfesser, G. A. Tetrahedron Lett. 1994, 35, 1661; (c) Engler, T.
A.; Gfesser, G. A.; Draney, B. W. J. Org. Chem. 1995, 60, 3700; (d) Ohara, H.;
Kiyokane, H.; Itoh, T. Tetrahedron Lett. 2002, 43, 3041; (e) Li, X.-C.; Ferreira, D.
Tetrahedron 2003, 59, 1501; (f) Yadav, J. S.; Reddy, B. V. S.; Kondaji, G. Synthesis
2003, 1100; (g) Itoh, T.; Kawai, K.; Hayase, S.; Ohara, H. Tetrahedron Lett. 2003,
44, 4081.
8. Cameron, D. W.; Crossley, M. J. Aust. J. Chem. 1978, 31, 1353.
9. Iwamoto, H.; Takuwa, A.; Hamada, K.; Fujiwara, R. J. Chem. Soc., Perkin Trans. 1
1999, 575.
Supplementary data
Supplementary data (compound data for new compounds 3aa,
4aa, 3ba, 4ba, 3cb, 3db, 3fa, 4fa, 3ac, and 4ac including ORTEP
drawing and CIF files of 3aa and 3ba) associated with this article
10. Recent review: (a) Schneider, C. Synthesis 2006, 3919; (b) Urabe, H.; Sato, F.. In
Lewis Acids in Organic Synthesis; Yamamoto, H., Ed.; Wiley-VCH: Weinheim,
2000; Vol. 10, p 766. Chapter 15; (c) Asahara, H.; Kubo, E.; Togaya, K.; Koizumi,
T.; Mochizuki, E.; Oshima, T. Org. Lett. 2007, 9, 3421.
11. (a) House, H. O. J. Am. Chem. Soc. 1955, 70, 3070; (b) Meinwald, J.; Labana, S. S.;
Chadha, M. S. J. Am. Chem. Soc. 1963, 85, 582; (c) Ranu, B. C.; Jana, U. J. Org.
Chem. 1998, 63, 8212; (d) Bhatia, K. A.; Eash, K. J.; Leonard, N. M.; Oswald, M.
C.; Mohan, R. S. Tetrahedron Lett. 2001, 42, 8129; (e) Robinson, M. W. C.; Davies,
A. M.; Buckle, R.; Mabbett, I.; Taylor, S. H.; Graham, A. E. Org. Biomol. Chem.
2009, 7, 2559.
References and notes
1. Recent examples: (a) Ali, Z.; Tanaka, T.; Iliya, I.; Iinuma, M.; Furusawa, M.; Ito,
T.; Nakaya, K.-I.; Murata, J.; Darnaedi, D. J. Nat. Prod. 2003, 66, 558; (b)
Stevenson, P. C.; Simmonds, M. S. J.; Yule, M. A.; Veitch, N. C.; Kite, G. C.; Irwin,
D.; Legg, M. Phytochemistry 2003, 63, 41; (c) Tanaka, H.; Oh-Uchi, T.; Etoh, H.;
Sako, M.; Sato, M.; Fukai, T.; Teteishi, Y. Phytochemistry 2003, 63, 597.
2. (a) Cagniant, P.; Cagniant, D. Adv. Heterocycl. Chem. 1975, 18, 337; (b) Bird, C.
W.; Cheeseman, G. W. H.. In Comprehensive Heterocyclic Chemistry; Katritzky, A.
R., Ed.; Pergamon: New York, 1984; Vol. 4, pp 89–153; (c) Donelly, D. M. X.;
Meegan, M. J.. In Comprehensive Heterocyclic Chemistry; Katritzky, A. R., Ed.;
Pergamon: NewYork, 1984; Vol. 4, pp 657–712; (d) Kataoka, K.; Shiota, T.;
Takeyasu, T.; Minoshima, T.; Watanabe, K.; Tanaka, H.; Mochizuki, T.; Taneda,
K.; Ota, M.; Tanabe, H.; Yamaguchi, H. J. Med. Chem. 1996, 39, 1262; (e) Janusz, J.
M.; Young, P. A.; Scherz, M. W.; Enzweiler, K.; Wu, L. I.; Gan, L.; Pikul, S.;
McDow-Dunham, K. L.; Johnson, C. R.; Senanayake, C. B.; Kellstein, D. E.; Green,
S. A.; Tulich, J. L.; Rosario-Jansen, T.; Magrisso, I. J.; Wehmeyer, K. R.;
Kuhlenbeck, D. L.; Eichhold, T. H.; Dobson, R. L. J. Med. Chem. 1998, 41, 1124.
3. (a) Shultz, A. G.; Yee, Y. K.; Berger, M. H. J. Am. Chem. Soc. 1977, 99, 8065; (b)
Gubin, J.; de Vogelaer, H.; Inion, H.; Houben, C.; Lucchett, J.; Mahaux, J.;
Rosseels, G.; Peiren, M.; Clinet, M.; Polster, P.; Chatelain, P. J. Med. Chem. 1993,
36, 1425; (c) Huang, H.-C.; Chamberlain, T. S.; Seibert, K.; Koboldt, C. M.;
Isakson, P. C.; Reitz, D. B. Bioorg. Med. Chem. Lett. 1995, 5, 2377; (d) Malamas, M.
S.; Sredy, J.; Moxham, C.; Katz, A.; Xu, W.; McDevitt, R.; Adebayo, F. O.; Sawicki,
D. R.; Seestaller, L.; Sullivan, D.; Taylor, J. R. J. Med. Chem. 2000, 43, 1293; (e)
Wyatt, P. G.; Allen, M. J.; Chilcott, J.; Gardner, C. J.; Livermore, D. G.; Mordaunt,
J. E.; Nerozzi, F.; Patel, M.; Perren, M. J.; Weingartgen, G. G.; Shabbir, S.;
Woollard, P. M.; Zhou, P. Bioorg. Med. Chem. Lett. 2002, 12, 1405.
12. General procedure for the preparation of 3aa and 4aa: To a solution of 2,6-
dimethyl-1,4-benzoquinone (136 mg, 1 mmol) and trans-stilbene oxide
(235 mg, 1.2 mmol) in dry chloroform (30 mL) was added boron trifluoride
diethyl etherate (380
lL, 3 mmol) at room temperature. The mixture was stirred
for 18 h, then quenched bythe addition of water. Theorganic layer separated was
dried over calcium chloride and concentrated in vacuo. The crude product was
purified by silica gel column chromatography using hexane–ether as the eluent.
4,6-Dimethyl-2,3-diphenylbenzofuran-5-ol (3aa): colorless prisms; mp
125.5ꢁ126.0 °C; 1H NMR (270 MHz, CDCl3) d 1.89 (s, 3H), 2.37 (s, 3H), 4.44 (s,
1H), 7.19ꢁ7.23 (m, 4H), 7.38ꢁ7.49 (m, 7H); 13C NMR (67.5 MHz, CDCl3) d 11.29,
17.15, 109.69, 115.03, 118.32, 121.74, 126.14, 127.55, 127.67, 128.14, 128.65,
129.95, 130.69, 130.92, 134.62, 147.82, 148.33, 149.98; IR (KBr) 3454 (br,
OH) cmꢁ1. Crystal structure of 3aa: C22H18O2, M = 314.4, monoclinic, space
group C12/c1 with a = 22.656(2), b = 20.763(2), c = 18.899(2) Å, b = 129.202(1),
V = 6889(1) Å3, Z = 16, Dc = 1.220 g/cm3, R = 0.0677, and Rw = 0.1780. 4,6-
Dimethyl-2,3-diphenyl-2,3-dihydrobenzofuran-5-ol (4aa): colorless crystal;
1H NMR (270 MHz, CDCl3) d 1.79 (s, 3H), 2.27 (s, 3H), 4.19 (s, 1H, OH), 4.45 (d,
1H, J = 5.9 Hz), 5.46 (d, 1H, J = 5.9 Hz), 6.65 (s, 1H), 7.13ꢁ7.44 (m, 10H); 13C NMR
(67.5 MHz, CDCl3) d 12.46, 16.77, 58.03, 92.52, 108.33, 121.09, 123.69, 125.25,
126.39, 126.89, 127.70, 127.81, 128.53, 128.79, 141.97, 142.80, 146.38, 153.39;
MS (EI) m/e = 316 (M+); HRMS calcd for C22H20O2: 316.1463. Found: 316.1472.
13. The coupling constants for trans-isomer of 4,6-substituted 2,3-diaryl-2,3-
dihydrobenzofuran-5-ols were reported as J = 5.9 to 6 Hz (Ref. 7c).
4. See some reviews: (a) Hosokawa, T.; Murahashi, S.-I. Acc. Chem. Res. 1990, 23,
49; (b) Kadieva, M. G.; Oganesyan, É. T. Chem. Heterocycl. Compd. 1997, 33,
1245; (c) Cacchi, S.; Fabrizi, G.; Goggiomani, A. Heterocycles 2002, 56, 613; (d)
Zeni, G.; Larock, R. C. Chem. Rev. 2004, 104, 2285; (e) Youn, S. W.; Eom, J. I. Org.
Lett. 2005, 7, 3355.
5. (a) Hosokawa, T.; Maeda, K.; Koga, K.; Moritani, I. Tetrahedron Lett. 1973, 10,
739; (b) Hosokawa, T.; Ohkata, H.; Moritani, I. Bull. Chem. Soc. Jpn. 1975, 48,
1533; (c) Kundu, N. G.; Pal, M.; Mahanty, J. S.; Dasgupta, S. K. J. Chem. Soc.,
Chem. Commun. 1992, 41; (d) Uozumi, Y.; Kato, K.; Hayashi, T. J. Am. Chem. Soc.
1997, 119, 5063; (e) Jiménez, M. C.; Miranda, M. A.; Tormos, R. J. Org. Chem.
14. Omura, K. J. Org. Chem. 1996, 61, 7156.
15. In Ref. 7b, the authors noted that coupling constants between the methine
protons at C2 and C3 are not sufficient for assigning stereochemistry. However,
the NOE data for dihydrobenzofurans 4 other than 4ac could not be measured
due to the overlap of the aromatic proton signals in 1H NMR.